Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $16.89 as of May 14th. TEVA’s forward P/E is 6.47 according to Yahoo Finance. Teva Pharmaceuticals, the world’s largest ...

With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the hybrid generics and innovative medicines giant. As part of a new bid ...

This week, Teva launched its most ambitious global campaign in years, ‘For Playground Earth,’ a fully integrated marketing push that reaffirms its heritage in outdoor adventure while inviting ...

Teva's Q4 earnings reveal significant headwinds, including declining U.S. generics revenue and rising costs in the API business, impacting overall profitability. Branded drugs like Austedo and ...

Teva Pharmaceutical Industries' Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. Management's cautious 2025 guidance sets a low bar, likely to be ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands among Wednesday’s worst-performing stocks. The stock market declined on Wednesday ...

Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping it will become a blockbuster drug - or one that generates annual sales ...

Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well ...

Kashmir Police have asked trekkers to inform police in advance about their routes after two trekkers were caught in an encounter between terrorists and security forces at Zabarwan near Srinagar ...

Teva CMO Eric Hughes, M.D., Ph.D. (Teva) Teva’s mid- and late-stage pipeline largely hinges on four drugs, each of which falls into one of the company’s historic specialties in neuroscience ...

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers ...

My watch chimes and I look down: two miles in, three to go. Then I look lower to my feet and remember I’m wearing Teva’s latest sandal, the Aventrail. For a moment, I was so lost in the ...